These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20681990)

  • 21. Carrier frequency of F508del mutation of cystic fibrosis in Indian population.
    Kapoor V; Shastri SS; Kabra M; Kabra SK; Ramachandran V; Arora S; Balakrishnan P; Deorari AK; Paul VK
    J Cyst Fibros; 2006 Jan; 5(1):43-6. PubMed ID: 16311077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Geographic distribution of cystic fibrosis transmembrane regulator gene mutations in Saudi Arabia.
    Banjar H
    East Mediterr Health J; 1999 Nov; 5(6):1230-5. PubMed ID: 11924117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
    Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
    PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].
    Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2021; 45(3 Suppl 1):1-37. PubMed ID: 34132083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [DNA analysis and gene diagnosis of cystic fibrosis].
    Kobayashi K
    Rinsho Byori; 1991 Oct; 39(10):1057-64. PubMed ID: 1722259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CFTR mutations in Turkish and North African cystic fibrosis patients in Europe: implications for screening.
    Lakeman P; Gille JJ; Dankert-Roelse JE; Heijerman HG; Munck A; Iron A; Grasemann H; Schuster A; Cornel MC; Ten Kate LP
    Genet Test; 2008 Mar; 12(1):25-35. PubMed ID: 18373402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of cystic fibrosis mutations in Israeli Jews.
    Orgad S; Neumann S; Loewenthal R; Netanelov-Shapira I; Gazit E
    Genet Test; 2001; 5(1):47-52. PubMed ID: 11336401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cystic fibrosis--the most frequent life-shortening autosomal recessive disease].
    Wieser R
    Wien Med Wochenschr; 2005 Jun; 155(11-12):268-72. PubMed ID: 16035387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotype and phenotype in cystic fibrosis.
    Zielenski J
    Respiration; 2000; 67(2):117-33. PubMed ID: 10773783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype-phenotype relationship for five CFTR mutations frequently identified in western France.
    Duguépéroux I; De Braekeleer M;
    J Cyst Fibros; 2004 Dec; 3(4):259-63. PubMed ID: 15698945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequencies of cystic fibrosis mutations in the Maine population: high proportion of unknown alleles in individuals of French-Canadian ancestry.
    Bayleran JK; Yan H; Hopper CA; Simpson EM
    Hum Genet; 1996 Aug; 98(2):207-9. PubMed ID: 8698344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy.
    Segat L; Morgutti M; Athanasakis E; Trevisiol C; Amaddeo A; Poli F; Crovella S
    Int J Immunogenet; 2010 Jun; 37(3):169-75. PubMed ID: 20193032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
    Southern KW; Patel S; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of 99% of CFTR gene mutations in Bulgarian-, Bulgarian Turk-, and Roma cystic fibrosis patients.
    Petrova G; Yaneva N; Hrbková J; Libik M; Savov A; Macek M
    Mol Genet Genomic Med; 2019 Aug; 7(8):e696. PubMed ID: 31245908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.
    Sharma H; Mavuduru RS; Singh SK; Prasad R
    Mol Hum Reprod; 2014 Sep; 20(9):827-35. PubMed ID: 24958810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Early bronchial inflammation in cystic fibrosis].
    Puchelle E
    J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cystic fibrosis carrier frequencies in populations of African origin.
    Padoa C; Goldman A; Jenkins T; Ramsay M
    J Med Genet; 1999 Jan; 36(1):41-4. PubMed ID: 9950364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the M1101K mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and complete detection of cystic fibrosis mutations in the Hutterite population.
    Zielenski J; Fujiwara TM; Markiewicz D; Paradis AJ; Anacleto AI; Richards B; Schwartz RH; Klinger KW; Tsui LC; Morgan K
    Am J Hum Genet; 1993 Mar; 52(3):609-15. PubMed ID: 7680525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular genetics principles in cystic fibrosis. An example of genetic illness in pneumology].
    Tümmler B; Stuhrmann M
    Internist (Berl); 2003 Jun; 44 Suppl 1():S7-15. PubMed ID: 14567084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.